John W. Beck, SVP, Finance & Operations, CFO at Ardea Biosciences, Inc./DE (RDEA), sold 2,500 shares at $20.15 ($50K) on 2009-08-14, disclosed to the SEC on 2009-08-17.
Scheduled sale ($50k) by SVP, Finance & Operations, CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RDEA | SELL | 2009-05-21 | $75K | — | Filing → |
| MBRX | SELL | 2007-06-21 | $27K | — | Filing → |
| MBRX | SELL | 2007-06-05 | $80K | — | Filing → |